Bhat, V.; Thu, K.L.; Goncalves Santiago, A.d.F.; Bonvissuto, A.C.; Ghasemi, F.; Goodale, D.; Roes, M.V.; Passos, D.T.; Dick, F.A.; Cescon, D.W.;
et al. Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer. Cancers 2025, 17, 3279.
https://doi.org/10.3390/cancers17203279
AMA Style
Bhat V, Thu KL, Goncalves Santiago AdF, Bonvissuto AC, Ghasemi F, Goodale D, Roes MV, Passos DT, Dick FA, Cescon DW,
et al. Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer. Cancers. 2025; 17(20):3279.
https://doi.org/10.3390/cancers17203279
Chicago/Turabian Style
Bhat, Vasudeva, Kelsie L. Thu, Anayra de Fatima Goncalves Santiago, Anna C. Bonvissuto, Farhad Ghasemi, David Goodale, Michael V. Roes, Daniel T. Passos, Frederick A. Dick, David W. Cescon,
and et al. 2025. "Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer" Cancers 17, no. 20: 3279.
https://doi.org/10.3390/cancers17203279
APA Style
Bhat, V., Thu, K. L., Goncalves Santiago, A. d. F., Bonvissuto, A. C., Ghasemi, F., Goodale, D., Roes, M. V., Passos, D. T., Dick, F. A., Cescon, D. W., Allan, A. L., & Parsyan, A.
(2025). Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer. Cancers, 17(20), 3279.
https://doi.org/10.3390/cancers17203279
